The orthopedic devices market size is poised to grow by $ 58.89 billion by 2032 from $ 48.08 Billion in 2022, exhibiting a CAGR of 2.10% during the forecast period 2023-2032.
Key Takeaway:
- By application, the knee orthopedic devices segment has held revenue share of over 29.51% in 2022.
- By products, the surgical devices segment has captured 56% revenue share in 2022. However, the accessories segment is growing at a CAGR of 3.5% from 2023 to 2032.
- North America region has accounted highest revenue share for 48% in 2022.
- Asia Pacific is poised to grow at a fastest CAGR from 2023 to 2032.
The main objective of this report is to define, describe, and forecast the global market by types, application, manufacturers, and regions. The report provides detailed information about the major factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the market. The report aims to strategically analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market. The report also attempts to forecast the market size of the 5 main regions: North America, Europe, Asia Pacific (APAC), Middle East and Africa (MEA), and Latin America. It strategically profiles the key market players and comprehensively analyzes their core competencies. It also tracks and analyzes competitive developments, such as joint ventures, mergers and acquisitions, new developments, and Research and Development (R&D) activities, in market.
Get a Sample: https://www.precedenceresearch.com/sample/1027
COVID-19 Impact
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the electric vehicle fuel cell market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Major companies operating in this area
- Medacta
- DePuySynthes
- Smith & Nephew
- Stryker
- Medtronic
- Zimmer Biomet
- MicroPort Scientific Corporation (Wright Medical Group)
- DJO Global
- ConforMIS
- NuVasive
- Globus Medical
Market Segmentation
By Product Type
- Joint Reconstruction
- Knee Replacement
- Revision Knee Replacement Implants
- Total Knee Replacement Implant
- Partial Knee Replacement Implant
- Elbow & Shoulder Replacement
- Hip Replacement
- Hip Resurfacing Implant
- Total Hip Replacement Implant
- Partial Hip Replacement Implant
- Revision Hip Replacement Implant
- Others
- Knee Replacement
- Orthopedic Prosthetics
- Upper Extremity Orthopedic Prosthetics
- Lower Extremity Orthopedic Prosthetics
- Spinal Devices
- Spinal Non-fusion Devices
- Spinal Fusion Devices
- Trauma Fixation
- Nails and Rods
- Metal Plates & Screws
- Pins/Wires
- Others
- Arthroscopy Devices
- Orthopedic Accessories
- Removal systems
- Bone cement
- Casting system
- Orthopedic Braces and Supports
- Upper Extremity Braces and Supports
- Low Extremity Braces and Supports
- Others
By End-user
- Ambulatory Surgical Centers
- Hospitals
- Orthopedic Clinics
- Others
By Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia Pacific
- China
- India
- Japan
- South Korea
- Middle East & Africa
- Latin America
Major highlights of Report:
- Figures related to sales volume, market remuneration, and segmental shares
- Featuring market dynamics
- Growth prospects and expansion graph
- PROCON study of direct & indirect sales channels
- Profiles of prominent traders, dealer, and distributors in the industry
Geographical landscape: North America, Europe, Asia-Pacific, South America, Middle East and Africa
- Industry forecasts based on region and at country level
- Data about sales volume recorded, industry share held, and profit margins amassed
- Overall remuneration and estimated growth rate for each regional market
Major Key Points Covered in Report:
Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.
Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.
Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.
Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.
Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sourcesa
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Orthopedic Devices Market, By Product
7.1. Orthopedic Devices Market, by Product Type, 2023-2032
7.1.1. Joint Reconstruction
7.1.1.1. Knee Replacement
7.1.1.2. Elbow & Shoulder Replacement
7.1.1.3. Hip Replacement
7.1.1.4. Market Revenue and Forecast (2020-2032)
7.1.2. Orthopedic Prosthetics
7.1.2.1. Market Revenue and Forecast (2020-2032)
7.1.3. Spinal Devices
7.1.3.1. Market Revenue and Forecast (2020-2032)
7.1.4. Trauma Fixation
7.1.4.1. Market Revenue and Forecast (2020-2032)
7.1.5. Arthroscopy Devices
7.1.5.1. Market Revenue and Forecast (2020-2032)
7.1.6. Orthopedic Accessories
7.1.6.1. Market Revenue and Forecast (2020-2032)
7.1.7. Orthopedic Braces and Supports
7.1.7.1. Market Revenue and Forecast (2020-2032)
7.1.8. Others
7.1.8.1. Market Revenue and Forecast (2020-2032)
Chapter 8. Global Orthopedic Devices Market, By Application
8.1. Orthopedic Devices Market, by Application, 2023-2032
8.1.1. Ambulatory Surgical Centers
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Orthopedic Clinics
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Orthopedic Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2020-2032)
9.1.2. Market Revenue and Forecast, by Application (2020-2032)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.1.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.1.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
9.2.6.2. Market Revenue and Forecast, by Application (2020-2032)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
9.3.6.2. Market Revenue and Forecast, by Application (2020-2032)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.4.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
9.4.6.2. Market Revenue and Forecast, by Application (2020-2032)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2020-2032)
9.5.2. Market Revenue and Forecast, by Application (2020-2032)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2020-2032)
9.5.3.2. Market Revenue and Forecast, by Application (2020-2032)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
9.5.4.2. Market Revenue and Forecast, by Application (2020-2032)
Chapter 10. Company Profiles
10.1. Medacta
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. DePuySynthes
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Smith & Nephew
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Stryker
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Medtronic
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Zimmer Biomet
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. MicroPort Scientific Corporation (Wright Medical Group)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. DJO Global
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. ConforMIS
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. NuVasive
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Globus Medical
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments